Financhill
Sell
35

CRDF Quote, Financials, Valuation and Earnings

Last price:
$2.12
Seasonality move :
11.94%
Day range:
$2.09 - $2.21
52-week range:
$1.90 - $5.64
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
268.67x
P/B ratio:
2.91x
Volume:
419.9K
Avg. volume:
732.3K
1-year change:
-9.83%
Market cap:
$142.1M
Revenue:
$683K
EPS (TTM):
-$0.79

Earnings Data

Next earnings date for CRDF
Feb 26
2026
Most recent earnings per share
-$0.17
Beat by $0.04
(Nov 6/2025)
Consensus Estimate
-$0.21
(Nov 6/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CRDF Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/26/2026 Q4 $100K -- -- -$0.20 --
11/06/2025 Q3 $121.4K $120K -$0.17 -$0.21 $0.04
07/29/2025 Q2 $106.3K $121K -$0.21 -$0.20 -$0.01
05/08/2025 Q1 $89.3K $109K -$0.20 -$0.19 -$0.02
02/27/2025 Q4 $94.2K $151K -$0.21 -$0.25 $0.03
11/07/2024 Q3 $70K $165K -$0.25 -$0.27 $0.02
08/08/2024 Q2 $58.8K $163K -$0.26 -$0.25 -$0.01
05/02/2024 Q1 $55K $205K -$0.22 -$0.25 $0.03
02/29/2024 Q4 $37.5K $156K -$0.21 -$0.28 $0.07
11/02/2023 Q3 -- -- -$0.22 -$0.30 $0.08
08/09/2023 Q2 -- -- -$0.25 -$0.25 $0.00
05/04/2023 Q1 -- -- -$0.25 -$0.22 -$0.03
03/02/2023 Q4 -- -- -$0.20 -$0.25 $0.05
11/03/2022 Q3 -- -- -$0.20 -$0.24 $0.04
08/04/2022 Q2 -- -- -$0.24 -- --
05/05/2022 Q1 -- -- -$0.25 -- --
02/24/2022 Q4 -- -- -$0.23 -- --
11/04/2021 Q3 -- -- -$0.17 -- --
08/05/2021 Q2 -- -- -$0.17 -- --
05/06/2021 Q1 -- -- -$0.14 -- --
02/25/2021 Q4 -- -- -$0.18 -- --
11/05/2020 Q3 -- -- -$0.19 -- --
08/11/2020 Q2 -- -- -$0.51 -- --
05/07/2020 Q1 -- -- -$0.41 -- --
12/31/2019 Q4 -- -- -$0.51 -- --
09/30/2019 Q3 -- -- -$0.69 -- --
06/30/2019 Q2 -- -- -$0.76 -- --
03/31/2019 Q1 -- -- -$1.02 -- --
12/31/2018 Q4 -- -- -$1.09 -- --
11/09/2018 Q3 -- -- -$1.10 -- --
06/30/2018 Q2 -- -- -$5.27 -- --
03/31/2018 Q1 -- -- -$6.23 -- --
02/26/2018 Q4 -- -- -$4.32 -- --
11/09/2017 Q3 -- -- -$8.46 -- --
08/09/2017 Q2 -- -- -$18.72 -- --
05/10/2017 Q1 -- -- -$23.04 -- --
03/15/2017 Q4 -- -- -$24.48 -- --
11/09/2016 Q3 -- -- -$24.48 -- --
08/04/2016 Q2 -- -- -$24.48 -- --
03/31/2016 Q1 -- -- -$25.92 -- --
12/31/2015 Q4 -- -- -$18.72 -- --

Cardiff Oncology, Inc. Earnings Questions

  • How Much did Cardiff Oncology, Inc. Generate in Revenue Last Quarter?

    Cardiff Oncology, Inc. reported $120K worth of top line sales in its most recent quarter.

  • Did Cardiff Oncology, Inc. Beat Earnings Last Quarter?

    Cardiff Oncology, Inc. announced earnings per share of -$0.17 which represents a beat of analyst forecast a -$0.21 per share.

  • Is Cardiff Oncology, Inc. Profitable?

    Cardiff Oncology, Inc. reported -$104K that represents -$0.00 per share over the last quarter.

  • What is the Analyst Consensus for Cardiff Oncology, Inc. EPS Next Year?

    Cardiff Oncology, Inc.'s earnings are forecast to decrease from -$0.95 per share to -$0.99 per share next year representing a decrease of -18.58%.

  • When is Cardiff Oncology, Inc.'s Earnings Date?

    Cardiff Oncology, Inc.'s next earnings date is February 26, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did SoFi Stock Drop?
Why Did SoFi Stock Drop?

Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…

Will Robinhood Win AI Investing?
Will Robinhood Win AI Investing?

Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
81
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Buy
56
SMX alert for Dec 6

SMX (Security Matters) Plc [SMX] is up 134.09% over the past day.

Buy
62
PRAX alert for Dec 6

Praxis Precision Medicines, Inc. [PRAX] is up 30.47% over the past day.

Sell
13
PSN alert for Dec 6

Parsons Corp. [PSN] is down 21.1% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock